Zurcher Kantonalbank (Zurich Cantonalbank)
BankPosition in SKYE — Skye Bioscience, Inc.
CIK 1368163
ZURICH, V8
Position in SKYE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31
-$8 QoQ
Shares Held
52
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SKYE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Zurcher Kantonalbank (Zurich Cantonalbank) holds $538,697,913 across 179 Biotechnology names. SKYE ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
377,013 | $168,351,385 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
365,451 | $69,088,511 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
88,871 | $68,665,289 | |
| 4 | INSM |
INSMED Inc
|
152,366 | $24,914,888 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
74,920 | $24,788,780 | |
| 6 | INCY |
Incyte Corp
|
210,788 | $19,839,366 | |
| 7 | RPRX |
Royalty Pharma plc
|
373,042 | $17,894,824 | |
| 8 | MRNA |
Moderna, Inc.
|
160,161 | $8,136,178 |
All Filings in SKYE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31 | 52 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39 | 52 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $115,011 | 29,265 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $133,120 | 31,847 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $34,786 | 21,878 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $61,014 | 21,560 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||